HCPCS Level II
J0834
Injection, cosyntropin, 0.25 mg
Codes near J0834
These sit next to J0834 in the CMS Level II file. All J codes
- J0799Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
- J0800Injection, corticotropin, up to 40 units
- J0801Injection, corticotropin (acthar gel), up to 40 units
- J0802Injection, corticotropin (ani), up to 40 units
- J0833Injection, cosyntropin, not otherwise specified, 0.25 mg
- J0840Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
- J0841Injection, crotalidae immune f(ab')2 (equine), 120 mg
- J0850Injection, cytomegalovirus immune globulin intravenous (human), per vial
- J0870Injection, imetelstat, 1 mg
- J0871Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00404-9839-99 | Cortrosyn | Henry Schein Inc. | 1 |
| 00548-5900-00 | Cortrosyn | Amphastar Pharmaceuticals, Inc. | 10 |
| 00781-3440-95 | Cosyntropin | Sandoz Inc. | 10 |
| 51662-1567-01 | Cosyntropin | HF Acquisition Co. LLC, DBA HealthFirst | 1 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.
Run it in Rivvi
Check every code on your export
Upload a claims or problem-list export. Rivvi flags codes that are not billable, replaced, or unspecified when a specific code exists.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.